Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE4.6700
- TODAY'S CHANGE (%)0.0700 (1.5217%)
- Bid / Lots4.4000/ 1
- Ask / Lots4.9100/ 3
- Open / Previous Close4.6400 / 4.6000
- Day Range
- 52 Week Range
- Volume626,708
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 8001 | 4.61 |
| 09:34 ET | 9253 | 4.69 |
| 09:36 ET | 13065 | 4.72 |
| 09:38 ET | 8377 | 4.755 |
| 09:39 ET | 4987 | 4.75 |
| 09:41 ET | 500 | 4.76 |
| 09:43 ET | 6374 | 4.72 |
| 09:45 ET | 9400 | 4.7 |
| 09:48 ET | 13588 | 4.7 |
| 09:50 ET | 3302 | 4.72 |
| 09:52 ET | 2402 | 4.7098 |
| 09:54 ET | 2058 | 4.72 |
| 09:56 ET | 1117 | 4.71 |
| 09:57 ET | 100 | 4.71 |
| 09:59 ET | 3600 | 4.68 |
| 10:01 ET | 503 | 4.674 |
| 10:03 ET | 2205 | 4.64 |
| 10:06 ET | 9200 | 4.615 |
| 10:08 ET | 7235 | 4.605 |
| 10:10 ET | 4700 | 4.61 |
| 10:12 ET | 100 | 4.605 |
| 10:14 ET | 9656 | 4.61 |
| 10:15 ET | 3868 | 4.61 |
| 10:17 ET | 1308 | 4.645 |
| 10:19 ET | 49600 | 4.645 |
| 10:21 ET | 1685 | 4.63 |
| 10:24 ET | 956 | 4.64 |
| 10:26 ET | 588 | 4.65 |
| 10:28 ET | 556 | 4.63 |
| 10:30 ET | 8910 | 4.585 |
| 10:32 ET | 21112 | 4.58 |
| 10:33 ET | 3832 | 4.59 |
| 10:35 ET | 11139 | 4.534 |
| 10:37 ET | 1500 | 4.55 |
| 10:39 ET | 1849 | 4.56 |
| 10:42 ET | 1500 | 4.58 |
| 10:44 ET | 400 | 4.59 |
| 10:46 ET | 600 | 4.565 |
| 10:48 ET | 390 | 4.56 |
| 10:50 ET | 2152 | 4.555 |
| 10:51 ET | 10113 | 4.59 |
| 10:53 ET | 799 | 4.58 |
| 10:55 ET | 1293 | 4.59 |
| 10:57 ET | 7293 | 4.6 |
| 11:00 ET | 100 | 4.6 |
| 11:02 ET | 200 | 4.585 |
| 11:04 ET | 6900 | 4.58 |
| 11:06 ET | 6761 | 4.5807 |
| 11:08 ET | 16304 | 4.5821 |
| 11:09 ET | 1500 | 4.59 |
| 11:11 ET | 7982 | 4.595 |
| 11:13 ET | 2500 | 4.605 |
| 11:15 ET | 1000 | 4.59 |
| 11:20 ET | 300 | 4.59 |
| 11:22 ET | 1099 | 4.575 |
| 11:24 ET | 100 | 4.58 |
| 11:26 ET | 2716 | 4.61 |
| 11:27 ET | 592 | 4.61 |
| 11:29 ET | 232 | 4.61 |
| 11:31 ET | 600 | 4.6 |
| 11:36 ET | 290 | 4.6 |
| 11:38 ET | 14460 | 4.61 |
| 11:40 ET | 100 | 4.615 |
| 11:42 ET | 8266 | 4.63 |
| 11:44 ET | 100 | 4.62 |
| 11:45 ET | 100 | 4.63 |
| 11:47 ET | 600 | 4.61 |
| 11:49 ET | 300 | 4.6 |
| 11:51 ET | 1844 | 4.6 |
| 11:54 ET | 1200 | 4.62 |
| 11:56 ET | 702 | 4.61 |
| 11:58 ET | 1300 | 4.6 |
| 12:00 ET | 717 | 4.62 |
| 12:02 ET | 392 | 4.62 |
| 12:03 ET | 2463 | 4.62 |
| 12:05 ET | 600 | 4.61 |
| 12:07 ET | 296 | 4.61 |
| 12:12 ET | 800 | 4.61 |
| 12:14 ET | 7499 | 4.605 |
| 12:16 ET | 100 | 4.6 |
| 12:18 ET | 700 | 4.6 |
| 12:21 ET | 2396 | 4.61 |
| 12:23 ET | 472 | 4.605 |
| 12:27 ET | 6200 | 4.6 |
| 12:32 ET | 300 | 4.59 |
| 12:34 ET | 100 | 4.575 |
| 12:36 ET | 400 | 4.575 |
| 12:38 ET | 800 | 4.57 |
| 12:39 ET | 300 | 4.58 |
| 12:41 ET | 100 | 4.575 |
| 12:43 ET | 300 | 4.5799 |
| 12:45 ET | 769 | 4.585 |
| 12:48 ET | 170 | 4.5805 |
| 12:50 ET | 100 | 4.58 |
| 12:52 ET | 1812 | 4.565 |
| 12:54 ET | 425 | 4.575 |
| 12:56 ET | 200 | 4.57 |
| 12:59 ET | 1100 | 4.565 |
| 01:01 ET | 1000 | 4.565 |
| 01:06 ET | 800 | 4.57 |
| 01:08 ET | 3136 | 4.555 |
| 01:10 ET | 100 | 4.56 |
| 01:14 ET | 200 | 4.56 |
| 01:15 ET | 1000 | 4.56 |
| 01:17 ET | 200 | 4.555 |
| 01:19 ET | 343 | 4.56 |
| 01:21 ET | 4900 | 4.555 |
| 01:24 ET | 413 | 4.56 |
| 01:26 ET | 7475 | 4.575 |
| 01:28 ET | 1400 | 4.585 |
| 01:30 ET | 1529 | 4.6 |
| 01:32 ET | 1912 | 4.595 |
| 01:35 ET | 2443 | 4.57 |
| 01:37 ET | 893 | 4.57 |
| 01:39 ET | 300 | 4.58 |
| 01:42 ET | 3127 | 4.59 |
| 01:44 ET | 200 | 4.6 |
| 01:46 ET | 100 | 4.6 |
| 01:48 ET | 800 | 4.61 |
| 01:51 ET | 100 | 4.605 |
| 01:53 ET | 100 | 4.605 |
| 01:55 ET | 100 | 4.61 |
| 01:57 ET | 200 | 4.6 |
| 02:00 ET | 706 | 4.6005 |
| 02:02 ET | 600 | 4.605 |
| 02:04 ET | 388 | 4.6 |
| 02:06 ET | 600 | 4.6 |
| 02:08 ET | 300 | 4.6 |
| 02:09 ET | 100 | 4.6 |
| 02:11 ET | 297 | 4.605 |
| 02:13 ET | 100 | 4.61 |
| 02:18 ET | 3591 | 4.63 |
| 02:20 ET | 1844 | 4.61 |
| 02:24 ET | 1100 | 4.6084 |
| 02:26 ET | 300 | 4.615 |
| 02:27 ET | 200 | 4.615 |
| 02:29 ET | 100 | 4.61 |
| 02:31 ET | 300 | 4.605 |
| 02:36 ET | 700 | 4.61 |
| 02:38 ET | 600 | 4.61 |
| 02:42 ET | 600 | 4.6 |
| 02:44 ET | 2998 | 4.595 |
| 02:45 ET | 2615 | 4.59 |
| 02:47 ET | 473 | 4.59 |
| 02:49 ET | 100 | 4.6 |
| 02:54 ET | 200 | 4.6 |
| 02:56 ET | 100 | 4.59 |
| 02:58 ET | 100 | 4.595 |
| 03:00 ET | 400 | 4.59 |
| 03:02 ET | 1150 | 4.6 |
| 03:03 ET | 352 | 4.599 |
| 03:05 ET | 7811 | 4.58 |
| 03:07 ET | 600 | 4.59 |
| 03:09 ET | 1535 | 4.6 |
| 03:12 ET | 574 | 4.6 |
| 03:14 ET | 1859 | 4.61 |
| 03:16 ET | 1902 | 4.61 |
| 03:18 ET | 200 | 4.61 |
| 03:25 ET | 3400 | 4.62 |
| 03:27 ET | 4987 | 4.63 |
| 03:30 ET | 1015 | 4.625 |
| 03:32 ET | 100 | 4.625 |
| 03:34 ET | 1138 | 4.62 |
| 03:36 ET | 5296 | 4.635 |
| 03:38 ET | 320 | 4.62 |
| 03:39 ET | 1226 | 4.62 |
| 03:41 ET | 1616 | 4.635 |
| 03:43 ET | 500 | 4.64 |
| 03:45 ET | 3800 | 4.645 |
| 03:48 ET | 7710 | 4.68 |
| 03:50 ET | 5118 | 4.68 |
| 03:52 ET | 7693 | 4.69 |
| 03:54 ET | 7648 | 4.68 |
| 03:56 ET | 5560 | 4.68 |
| 03:57 ET | 13613 | 4.69 |
| 03:59 ET | 53458 | 4.67 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.2B | -3.9x | --- |
Enliven Therapeutics Inc | 1.2B | -14.2x | --- |
Cullinan Therapeutics Inc | 1.1B | -6.4x | --- |
Disc Medicine Inc | 1.3B | -13.5x | --- |
Centessa Pharmaceuticals PLC | 1.2B | -7.6x | --- |
Sana Biotechnology Inc | 1.3B | -4.2x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- IR Contact Officer, Vice President - Business Strategy and Planning
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.06 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -3.9x |
Price/Sales (TTM) | 116.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,670.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
